Haris Ali

Dr. Haris Ali is an Associate Professor in the Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California. He also serves as the Section Leader of the Myeloproliferative Neoplasms (MPN) Program since 2021. Dr. Ali is board-certified in internal medicine, medical oncology, and hematology, with clinical expertise in hematologic malignancies and hematopoietic cell transplantation.

Dr. Ali received his medical degree from Rawalpindi Medical College in Pakistan in 2001. He completed his internal medicine internship at the University of Maryland's Harbor Hospital Center, followed by residency at Loma Linda University Medical Center where he was named chief resident. He then completed hematology/oncology fellowship at University of Texas Southwestern and hematopoietic cell transplantation fellowship at City of Hope.

Dr. Ali's research focuses on myeloproliferative neoplasms, particularly myelofibrosis, polycythemia vera, and essential thrombocythemia. His work explores novel targeted and immunotherapies for these conditions, as well as strategies for prevention and treatment of graft-versus-host disease following transplantation. His research has significant clinical implications for improving outcomes in patients undergoing hematopoietic stem cell transplantation.

Analysis of Dr. Ali's recent publications (2021-2023) reveals a strong focus on myeloproliferative disorders, graft-versus-host disease, and hematopoietic stem cell transplantation. His work spans clinical trials, retrospective analyses, and systematic reviews, with particular emphasis on risk stratification, novel therapeutic approaches, and managing complications of transplantation. A significant portion of his recent work addresses the intersection of hematologic malignancies and infectious diseases, particularly related to SARS-CoV2 and vaccination in immunocompromised patients.

• Fellow of the American College of Physicians (2023)
• Recognition Award for First Place in American Society of Clinical Oncology In-service Exam (2011 & 2012)
• Recognition Award for First Place in American Society of Hematology In-service Exam (2011 & 2012)
• Best Poster, American College of Physicians, California Chapter poster competition (2006)
• Winner Doctor's Dilemma, American College of Physicians, Maryland Chapter (2003)

Dr. Ali is actively involved in clinical research through multiple clinical trials and collaborative studies. He works closely with the Hematology & Hematopoietic Cell Transplantation and Leukemia Research Teams at City of Hope, focusing on improving outcomes for patients with myeloproliferative neoplasms and acute leukemias. His work has important implications for developing more effective treatment strategies for these challenging conditions.

Dr. Ali leads the Myeloproliferative Neoplasms Program at City of Hope, where his team conducts research on novel therapeutic approaches for myelofibrosis, polycythemia vera, and essential thrombocythemia. The program focuses on both clinical care and translational research to improve patient outcomes.